The Alzheimer’s Disease and Dementia SBMT Subcommittee, focuses on research on novel early diagnostics, therapeutics and management of Alzheimer’s disease and neurodegenerative diseases and dementia.
MD | Research Fellow (2023)
WBMF Golden Axon Award, 2023 | Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
President at StemVax, Chief Scientific Officer at T-Neuro Pharma, Inc. Professor and research scientist at Cedars-Sinai Medical Center
Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
Margaret Fahnestock is a molecular neurobiologist at McMaster University. She is a professor in the Department of Psychiatry and Behavioural Neurosciences, as well as an Associate Member of the Department of Biology and a member of the Medical Sciences graduate program. Margaret has been working with McMaster since 1991, when she joined the Department of Biomedical Sciences.
14th President of SBMT (2016-2017), WBMF Golden Axon Award, 2017 | Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
Dr. Ashford is a Clinical Professor of Psychiatry and Behavioral Sciences (affiliated) at Stanford University and the Director of the War Related Illness and Injury Study Center at the VA Palo Alto Health Care System. Dr. Ashford also serves as a Senior Research Scientist at the Stanford / VA Aging and Alzheimer’s Disease Clinical Research Centers. He is Chair of the Memory Screening Advisory Board of the Alzheimer’s Foundation of America and a Senior Editor of the Journal of Alzheimer’s Disease.
1 / 1
860 Via De La Paz, Suite E-1 Pacific Palisades, CA 90272
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.